多奈单抗
Donanemab
ChemLeader
Catalog No:
CAS No.:
MDLNo:
Formula:
MW:
Size
Quantity
- +
Product Overview
Product Name Donanemab
CAS1931944-80-7
Storage conditionstore at -20°C | Shipping with blue ice.
Security information
Product details

Donanemab (LY3002813) is a potent humanized IgG1 mAb targeting N-terminal pyroglutamate β-amyloid (Aβ), slowing tau progression and reducing amyloid in early Alzheimer's disease treatment.

Related literature
PMID: 33720637 DOI: 10.1056/NEJMoa2100708
Related
Sorry, no related items
History
Anti-Human CD3xCD19 Bispecific Antibody(Blinatumomab; Blincyto; MT103; MEDI-538; MEDI 538; Anti-human CD3 CD19; Human CD3 CD19 bispecific)
Donanemab
Vantictumab (Anti-FZD)
Sevirumab
Anti-EPHA3 (ifabotuzumab biosimilar) mAb
Anti-CD40 (iscalimab biosimilar)mAb
Dulaglutide, Acetate salt
Etaracizumab
Icrucumab (Anti-VEGFR1 / FLT1)
Nerelimomab